These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38826133)

  • 1. PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I.
    Liu Z; Li X; Muhammad A; Sun Q; Zhang Q; Wang Y; Wang Y; Ren J; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2024 Jun; ():. PubMed ID: 38826133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and prognostic significance of ALOX12B and PACSIN1 expression in gastric cancer by genome-wide RNA expression and methylation analysis.
    Liu Z; Li L; Li X; Hua M; Sun H; Zhang S
    J Gastrointest Oncol; 2021 Oct; 12(5):2082-2092. PubMed ID: 34790376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
    Zhang W; Chen L; Liu J; Chen B; Shi H; Chen H; Qi H; Wu Z; Mao X; Wang X; Huang Y; Li J; Yu Z; Zhong M; Wang T; Li Q
    J Exp Clin Cancer Res; 2024 Apr; 43(1):114. PubMed ID: 38627815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer.
    Yamamoto K; Venida A; Perera RM; Kimmelman AC
    Autophagy; 2020 Aug; 16(8):1524-1525. PubMed ID: 32459143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.
    Zhang Z; Song B; Wei H; Liu Y; Zhang W; Yang Y; Sun B
    Drug Resist Updat; 2024 Mar; 73():101040. PubMed ID: 38228036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACSIN1 is indispensable for amphisome-lysosome fusion during basal autophagy and subsets of selective autophagy.
    Oe Y; Kakuda K; Yoshimura SI; Hara N; Hasegawa J; Terawaki S; Kimura Y; Ikenaka K; Suetsugu S; Mochizuki H; Yoshimori T; Nakamura S
    PLoS Genet; 2022 Jun; 18(6):e1010264. PubMed ID: 35771772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
    Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC
    Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3.
    Yang Y; Nan Y; Du YH; Huang SC; Lu DD; Zhang JF; Li X; Chen Y; Zhang L; Yuan L
    World J Gastroenterol; 2023 Jul; 29(27):4317-4333. PubMed ID: 37545635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Yu Y; Meng LL; Chen XY; Fan HN; Chen M; Zhang J; Zhu JS
    Cell Signal; 2023 Aug; 108():110699. PubMed ID: 37149073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells.
    Oh DS; Lee HK
    Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.
    Neeley YC; McDonagh KT; Overwijk WW; Restifo NP; Sanda MG
    Prostate; 2002 Nov; 53(3):183-91. PubMed ID: 12386918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo PACSIN1 Gene Variant Found in Childhood Lupus and a Role for PACSIN1/TRAF4 Complex in Toll-like Receptor 7 Activation.
    Xie C; Zhou H; Athanasopoulos V; Shen Q; Zhang Y; Meng X; Burgio G; Arsov T; Lungu AC; Zhang P; Qin Y; Ma J; Wu X; Jiang X; Ding H; Meng Y; Shen N; He Y; Vinuesa CG
    Arthritis Rheumatol; 2023 Jun; 75(6):1058-1071. PubMed ID: 36622335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.
    Zhang Q; Xiu B; Zhang L; Chen M; Chi W; Li L; Guo R; Xue J; Yang B; Huang X; Shao ZM; Huang S; Chi Y; Wu J
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36252997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
    Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
    Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity.
    Peng L; Zhou L; Li H; Zhang X; Li S; Wang K; Yang M; Ma X; Zhang D; Xiang S; Duan Y; Wang T; Sun C; Wang C; Lu D; Qian M; Wang Z
    Cell Rep; 2024 Apr; 43(4):114003. PubMed ID: 38527062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
    Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
    Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation.
    Zhang B; Li J; Hua Q; Wang H; Xu G; Chen J; Zhu Y; Li R; Liang Q; Wang L; Jin M; Tang J; Lin Z; Zhao L; Zhang D; Yu D; Ren J; Zhang T
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36596591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.
    Yang Q; Lv Z; Wang M; Kong M; Zhong C; Gao K; Wan X
    J Exp Clin Cancer Res; 2024 Feb; 43(1):54. PubMed ID: 38383447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune infiltration profiling in gastric cancer and their clinical implications.
    Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
    Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.